Professor Jacob Sherkow, an expert on intellectual property and the biosciences, has been named one of 20 emerging leaders in health and medicine by the National Academy of Medicine (NAM).
The prestigious list includes early- to mid-career professionals in health-related fields, including science, medicine, bioengineering, policy, law, and ethics. Program participants serve a three-year term, during which they take part in events and activities hosted by the National Academies of Sciences, Engineering, and Medicine and collaborate on health-related work across sectors.
NAM president Victor J. Dzau said, “These exceptional individuals were selected to the National Academy of Medicine’s Emerging Leaders in Health and Medicine program for their leadership attributes and because they are poised to shape the future of health and medicine.”
Professor Sherkow, who is affiliated with NYLS’s Innovation Center on Law and Technology, is a leading voice in the dispute over who owns the technology behind CRISPR—a powerful new gene-editing tool with the potential to treat disease and generate enormous profit. He is often quoted in national and international press, including The New York Times, The Washington Post, Scientific American, NPR, and many other outlets on CRISPR and related issues. He has authored dozens of articles in both traditional law reviews and scientific journals, including the Yale Law Journal, the Stanford Law Review, the Duke Law Journal, Science, and Nature. He is also active in scholarly communities dedicated to ethical and policy discussions at the intersection of biotechnology and law.
- Read about NAM emerging leaders